These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28753842)

  • 1. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.
    Abbosh P; Sundararajan S; Millis SZ; Hauben A; Reddy S; Geynisman DM; Uzzo R
    Eur Urol Focus; 2018 Dec; 4(6):969-971. PubMed ID: 28753842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
    Roldan-Romero JM; Santos M; Lanillos J; Caleiras E; Anguera G; Maroto P; García-Donas J; de Velasco G; Martinez-Montes ÁM; Calsina B; Monteagudo M; Letón R; Leandro-García LJ; Montero-Conde C; Cascón A; Robledo M; Rodriguez-Antona C
    Mod Pathol; 2020 Dec; 33(12):2580-2590. PubMed ID: 32616874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling in renal cell carcinoma.
    Dizman N; Philip EJ; Pal SK
    Nat Rev Nephrol; 2020 Aug; 16(8):435-451. PubMed ID: 32561872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.
    Becerra MF; Reznik E; Redzematovic A; Tennenbaum DM; Kashan M; Ghanaat M; Casuscelli J; Manley B; Jonsson P; DiNatale RG; Blum KA; Durack JC; Solomon SB; Arcila ME; Bourque C; Socci N; Carlo MI; Lee CH; Voss MH; Feldman DR; Motzer RJ; Coleman JA; Russo P; Cheng EH; Hakimi AA; Hsieh JJ
    Eur Urol Focus; 2018 Dec; 4(6):986-994. PubMed ID: 29066084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.
    McCullar B; Pandey M; Yaghmour G; Hare F; Patel K; Stein K; Feldman R; Chandler JC; Martin MG
    Breast Cancer Res Treat; 2016 Jul; 158(1):195-202. PubMed ID: 27329168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
    Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
    Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling provides insight into chromophobe renal cell carcinoma.
    Cancer Discov; 2014 Nov; 4(11):OF16. PubMed ID: 25367957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
    Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
    Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics and clinical correlates of renal cell carcinoma.
    Mitchell TJ; Rossi SH; Klatte T; Stewart GD
    World J Urol; 2018 Dec; 36(12):1899-1911. PubMed ID: 30099580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
    Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
    Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
    Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.
    Wang Z; Kim TB; Peng B; Karam J; Creighton C; Joon A; Kawakami F; Trevisan P; Jonasch E; Chow CW; Canales JR; Tamboli P; Tannir N; Wood C; Monzon F; Baggerly K; Varella-Garcia M; Czerniak B; Wistuba I; Mills G; Shaw K; Chen K; Sircar K
    Clin Cancer Res; 2017 Nov; 23(21):6686-6696. PubMed ID: 28710314
    [No Abstract]   [Full Text] [Related]  

  • 14. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
    Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
    Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling.
    Pal SK; Choueiri TK; Wang K; Khaira D; Karam JA; Van Allen E; Palma NA; Stein MN; Johnson A; Squillace R; Elvin JA; Chmielecki J; Yelensky R; Yakirevich E; Lipson D; Lin DI; Miller VA; Stephens PJ; Ali SM; Ross JS
    Eur Urol; 2016 Sep; 70(3):516-21. PubMed ID: 26149668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
    Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma.
    Kapur P; Zhong H; Le D; Mukhopadhyay R; Miyata J; Carrillo D; Rakheja D; Rajaram S; Durinck S; Modrusan Z; Brugarolas J
    JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38775158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Analysis Reveals the Important Role of the
    Lai YC; Wang WC
    Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.
    Dagher J; Kammerer-Jacquet SF; Dugay F; Beaumont M; Lespagnol A; Cornevin L; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA
    Virchows Arch; 2017 Jul; 471(1):107-115. PubMed ID: 28488172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.